Card91 offers plug-and-play payment infrastructure as a service for businesses that want to issue, control, view, and approve payments. It assists businesses and banks in the launch of co-branded cards and the simplification of business payments. The company offers a card issuance platform for businesses that manage the payment flow from customer onboarding to transaction processing to data reconciliation. Card91 allows news age payment use cases via Card issuance and Management by empowering businesses with payment decisioning and transaction control.
ekincare is a patent-pending AI-powered integrated health benefits platform helping organizations and Employees with a Preventive, Predictive, and Highly Personalised Healthcare solution. Trusted by many fortune 500 companies ekincare redefines healthcare by being India's first personal health assistant using technology, analytics, and curated services. The integrated platform provides access to a multitude of online and offline healthcare services such as 24*7 chat with a doc, health check-ups, medicines purchase and delivery, Health coach programs, Mental wellness programs, Gyms & Fitness services, etc
AVIOM India is a housing finance company facilitating families in mostly semi-urban areas. The company provides financial assistance for home buying, improvement, extension, and construction to families from semi-formal, informal sectors. AVIOM provides home loans without any income documents.
Strata is a fractional real estate investment platform that makes investing in premium commercial properties easy, transparent, & affordable. The company focuses on offering investors premium properties with Grade A clients across India. Thanks to its fractional investment model, Strata is able to offer these investments for as low as Rs. 25 lakhs per fraction.Strata also offers a resale platform which investors can use to sell their holding at any time. The company looks after all the aspects of managing a property, from disbursing rent, handling tenants to arranging the eventual sale of the asset.
Private Equity Round in 2021
Veeda Clinical Research is a clinical Contract Research Organisation in India with a diverse product offering and a geographical footprint.
HungerBox is a full-stack B2B food and beverage technology company that provides food solutions for corporate. It provides an online platform that allows employees to order food and get delivery service for office and corporate events from the cafeteria. HungerBox aims to enhance the productivity of corporate employees by providing them a technology-driven food experience that is safe and healthy. It was founded in 2015 by Sandipan Mitra and Uttam Kumar and is based in Bangalore, India.
HungerBox is a full-stack B2B food and beverage technology company that provides food solutions for corporate. It provides an online platform that allows employees to order food and get delivery service for office and corporate events from the cafeteria. HungerBox aims to enhance the productivity of corporate employees by providing them a technology-driven food experience that is safe and healthy. It was founded in 2015 by Sandipan Mitra and Uttam Kumar and is based in Bangalore, India.
HungerBox is a full-stack B2B food and beverage technology company that provides food solutions for corporate. It provides an online platform that allows employees to order food and get delivery service for office and corporate events from the cafeteria. HungerBox aims to enhance the productivity of corporate employees by providing them a technology-driven food experience that is safe and healthy. It was founded in 2015 by Sandipan Mitra and Uttam Kumar and is based in Bangalore, India.
HungerBox is a full-stack B2B food and beverage technology company that provides food solutions for corporate. It provides an online platform that allows employees to order food and get delivery service for office and corporate events from the cafeteria. HungerBox aims to enhance the productivity of corporate employees by providing them a technology-driven food experience that is safe and healthy. It was founded in 2015 by Sandipan Mitra and Uttam Kumar and is based in Bangalore, India.
Cointribe operates an online lending marketplace that enables small business to get loans efficiently by undertaking the complete loan cycle activity from sourcing to risk assessment to fulfilment to collections. Multiple banks and NBFCs lend through the CoinTribe Marketplace trusting it's risk assessment algorithms. It's the only SME marketplace to have back-tested it's algorithm with 3 large banks. It also holds to its credit of having carried out an Assignment based downsell of its AUM with 1 year of lending operations. Cointribe was founded by Amit Sachdev, Rohit Lohia and Manish Chaudhari in 2015 and is headquartered in Gurgaon, India.
Portea Medical is India’s home healthcare pioneer and the largest and fastest growing provider of in-home medical care in India today with a 24-city network. Portea’s comprehensive services encompass geriatric care, post-operative care, palliative care and physiotherapy. The company offers home visits from physiotherapists, nursing attendants, nurses and doctors. In addition, Portea also provides collection of lab samples from patients’ homes and medical equipment on hire, bringing the entire gamut of healthcare services to a patient’s doorstep.
Niyogin operates as a non-banking finance company in India. It is involved in loans, finance, and investment, as well as lending and allied activities to micro, small, and medium enterprises.
Vyome Biosciences is an innovation-driven company, with a vision to develop novel drugs for antibiotics-resistant acne and other opportunist pathogens through a unique pipeline of antibiotics that retard resistance development. Vyome’s development platform is completely risk mitigated. Vyome has a deep pipeline of IP based products targeting multiple indications. The *lead molecule (VB 1953)*, which targets the huge unmet need in the drug resistant acne prescription market, will be entering the clinical phase with *USFDA IND Application Filing in Q4 2015*. Vyome has state-of-the-art infrastructure facilities to carry out all its research and lab development work, with full-fledged formulation, analytical, chemistry, biology & molecular biology, clinical and the regulatory divisions. The infrastructure and the team enables Vyome to conceive ideas, develop them and commercialize them at a rapid pace.
Vyome Biosciences is an innovation-driven company, with a vision to develop novel drugs for antibiotics-resistant acne and other opportunist pathogens through a unique pipeline of antibiotics that retard resistance development. Vyome’s development platform is completely risk mitigated. Vyome has a deep pipeline of IP based products targeting multiple indications. The *lead molecule (VB 1953)*, which targets the huge unmet need in the drug resistant acne prescription market, will be entering the clinical phase with *USFDA IND Application Filing in Q4 2015*. Vyome has state-of-the-art infrastructure facilities to carry out all its research and lab development work, with full-fledged formulation, analytical, chemistry, biology & molecular biology, clinical and the regulatory divisions. The infrastructure and the team enables Vyome to conceive ideas, develop them and commercialize them at a rapid pace.
Private Equity Round in 2006
IARC is a securitization and reconstruction company.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.